Article
ABCB1 genetic variant and its associated tacrolimus pharmacokinetics affect renal function in patients with rheumatoid arthritis.
Clinica chimica acta; international journal of clinical chemistry - 20 May 2015
Naito Takafumi, Mino Yasuaki, Aoki Yuki, Hirano Kumi, Shimoyama Kumiko, Ogawa Noriyoshi, Kagawa Yoshiyuki, Kawakami Junichi
Abstract excerpt
BACKGROUND: This study aimed to evaluate the blood exposure of and clinical responses to tacrolimus based on genetic variants of CYP3A5 and ABCB1 in patients with rheumatoid arthritis. METHODS: Seventy rheumatoid arthritis patients treated with oral tacrolimus once daily were enrolled. Blood conc...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
